Company page

Immuneering Corporation

Immuneering Corporation (ticker: IMRX) is a public company based in the United States, focusing on innovative solutions in the biotechnology sector. With a market capitalization of approximately $285.3 million, the company is dedicated to advancing its research and development efforts. Immuneering aims to leverage its expertise to address unmet medical needs and improve patient outcomes.